Recombinant Pvs48/45 Antigen Expressed in E. coli Generates Antibodies that Block Malaria Transmission in Anopheles albimanus Mosquitoes

EuGene: maximizing synthetic gene design for heterologous expression

(2012) P. Gaspar et al.   BIOINFORMATICS

Plasmodium vivax gametocyte protein Pvs230 is a transmission-blocking vaccine candidate

(2012) Mayumi Tachibana et al.   VACCINE

The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania

(2010) Teun Bousema et al.   PLoS One

Intranasal and intramuscular immunization with Baculovirus Dual Expression System-based Pvs25 vaccine substantially blocks Plasmodium vivax transmission

(2010) Andrew M. Blagborough et al.   VACCINE

Acquired Immunity to Malaria

(2009) D. L. Doolan et al.   CLINICAL MICROBIOLOGY REVIEWS

Post-translational modifications in Plasmodium: More than you think!

(2009) Duk-Won Doug Chung et al.   MOLECULAR AND BIOCHEMICAL PARASITOLOGY

Plasmodium genomics: latest milestone

(2009) Arnab Pain et al.   NATURE REVIEWS MICROBIOLOGY

A Potent Malaria Transmission Blocking Vaccine Based on Codon Harmonized Full Length Pfs48/45 Expressed in Escherichia coli

(2009) Debabani Roy Chowdhury et al.   PLoS One

Heterologous expression of plasmodial proteins for structural studies and functional annotation

(2008) Lyn-Marie Birkholtz et al.   MALARIA JOURNAL

Comparative genomics of the neglected human malaria parasite Plasmodium vivax

(2008) Jane M. Carlton et al.   NATURE

Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51

(2008) Yimin Wu et al.   PLoS One

Correctly folded Pfs48/45 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in mice

(2008) N. S. Outchkourov et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA